Publications and communications of Géraldine Piel

Degey, M., Berger, M., Evrard, B., & Piel, G. (31 January 2024). New amphiphilic polymers with variable length and number of lipid chains as alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. CIRM DAY - Scientific day, Liege, Belgium.

Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (31 January 2024). Optimization of liposomal composition to efficiently encapsulate dexamethasone or dexamethasone phosphate and enable their sustained release [Poster presentation]. CIRM Day, Liège, Belgium.

Gallez, A., Nys, G., Wuidar, V., Dias Da Silva, I., Taziaux, M., Kinet, V., Tskitishvili, E., Noël, A., Foidart, J.-M., Piel, G., Fillet, M., & Pequeux, C. (03 June 2023). Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment. International Journal of Molecular Sciences, 24 (11), 9718. doi:10.3390/ijms24119718

Penoy, N., Delma, K. L., Grignard, B., Evrard, B., & Piel, G. (23 May 2023). The use of supercritical CO2 to develop liposomes encapsulating active pharmaceutical ingredients for pulmonary administration [Poster presentation]. 19th European Meeting on Supercritical Fluids, Budapest, Hungary.

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (28 April 2023). Development of optimized liposomes for sustained-release transtympanic administration [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (01 February 2023). Development of a sustained-release form of dexamethasone for the local treatment of sensorineural hearing loss [Poster presentation]. CIRM Day, Liège, Belgium.

Delma, K. L., Penoy, N., Sakira, A. K., EGREK, S., Sacheli, R., Grignard, B., Hayette, M.-P., Issa Somé, T., Evrard, B., Semdé, R., & Piel, G. (11 January 2023). Use of supercritical CO2 for the sterilization of liposomes: Study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 183, 112 - 118. doi:10.1016/j.ejpb.2023.01.002

Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010

Warnon, C., Bouhjar, K., Ninane, N., Verhoyen, M., Fattaccioli, A., Fransolet, M., Lambert de Rouvroit, C., Poumay, Y., Piel, G., Mottet, D., & Debacq-Chainiaux, F. (12 July 2021). HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts. Aging, 13, 17978-18005. doi:10.18632/aging.203304

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (06 April 2021). Double Encapsulation in liposomes for pulmonary administration produced by an innovative supercritical process [Paper presentation]. Controlled Release Society BeNeLux&France Early Career Scientists Meeting (online).

Penoy, N., Koch, N., Grignard, B., Evrard, B., & Piel, G. (March 2021). The quality by design strategy to prepare different liposomes formulations by a new supercritical fluid method [Poster presentation]. APGI Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Ledoux, A., Coelho Cristino Mamede, L. C., Palazzo, C., Furst, T., Jansen, O., De Tullio, P., Kagisha, V., Pendeville-Samain, H., Fillet, M., Piel, G., & Frederich, M. (18 May 2020). Heparin-Coated Liposomes Improve Antiplasmodial Activity and Reduce the Toxicity of Poupartone B. Planta Medica International Open, 7 (e), 73–80. doi:10.1055/a-1158-0569

Ilangala Booka, A., COBRAIVILLE, G., EVRARD, A., Sonveaux, Lechanteur, A., Piel, G., & Fillet, M. (11 December 2019). LC-UV as tool for nanovectorized anticancer peptide quality control: evaluation of encapsulation efficiency [Poster presentation]. 2nd Edition of CIRM day, Liege, Belgium.

Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium.

Sounouvou, A. G. H. T., Toukourou, H., Lechanteur, A., Piel, G., Quetin-Leclercq, J., Gbaguidi, F., & Evrard, B. (11 December 2019). Development of dermatological dosage forms based on essential oils for the treatment of common skin infections [Paper presentation]. 2nd CIRM day, Liege, Belgium.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (August 2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape [Paper presentation]. 12th International Conference and Workshop on Biological barriers, Saarbruck, Germany.

Piel, G. (12 July 2018). Barriers and challenges to nanomedicine developments [Paper presentation]. NANOMED EMJMD Workshop, Paris, France.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France.

Bigazzi, W., Dufour, G., De Tullio, P., Piel, G., Cataldo, D., & Evrard, B. (June 2017). Interest of cylodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide [Poster presentation]. EuroDrying’2017 – 6th European Drying Conference, Liège, Belgium.

Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.

Furst, T., & Piel, G. (12 December 2014). MUCOADHESIVE HYDROXYETHYL-CELLULOSE SPONGES AS DELIVERY SYSTEM FOR VAGINAL APPLICATION [Paper presentation]. Biopharmacy Day, Vlaardingen, Netherlands.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium.

Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal.

Frère, A., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (28 August 2014). Polyplex based on polycarbonate polymesr for an efficient delivery of an anti-angiogenic siRNA [Paper presentation]. Translational Nanomedicine, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 3rd NanoFar Autumn School, Brussels, Belgium.

Frère, A., Krier, F., Evrard, B., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France.

Frère, A., Peixoto, P., Mottet, D., & Piel, G. (17 October 2013). Polyplexes based on polycarbonate polymers and siRNA against HDAC7 for a targeted anti-angiogenic therapy [Paper presentation]. 17th forum of Pharmaceutical Sciences, Spa, Belgium.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium.

Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium.

Frère, A., Kawalec, M., Collard, L., Matheus, N., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (22 October 2012). Characterization and transfection experiments of polyplexes targeting HDAC7 [Poster presentation]. NanoFar Autumn School, Angers, France.

Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France.

Piel, G. (20 May 2011). Nanotechnology based anti-cancer drug delivery systems: current developments and perspectives [Paper presentation]. GIGA cancer day 2011, Liège, Belgium.

Grammenos, A., Joset, A., Leyh, B., Piel, G., & Hoebeke, M. (2011). A combination of ESR and SANS techniques to explore the cyclodextrin action on membranes. Current Medicinal Chemistry, 76.

Berton, A., Piel, G., & Evrard, B. (2011). Powdered lipid nano and microparticles : production and applications. Recent Patents on Drug Delivery and Formulation, 5 (3), 188-200. doi:10.2174/187221111797200588

Grammenos, A., Mouithys-Mickalad, A., Guelluy, P.-H., Lismont, M., Piel, G., & Hoebeke, M. (2010). ESR technique for non invasive way to quantify cyclodextrins effect on cell membranes. Biochemical and Biophysical Research Communications, 1-5. doi:10.1016/j.bbrc.2010.06.050

Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (26 January 2010). Développement et validation d'une méthode de dosage de la glucosamine par SPE/LC/MS dans le plamsa canin [Paper presentation]. Forum des jeunes chercheurs du C.I.R.M, Liège, Belgium.

Castagne, D., Dive, G., Evrard, B., Frederich, M., & Piel, G. (2010). Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins. Journal of Pharmacy and Pharmaceutical Sciences, 13 (2), 362-377. doi:10.18433/j3bs34

Hubert, C., Houari, S., Lecomte, F., Houbart, V., De Bleye, C., Fillet, M., Piel, G., Rozet, E., & Hubert, P. (01 December 2009). Développement et validation d'une méthode de dosage de la glucosamine par SPE/HILIC/MS dans le plamsa de chien [Poster presentation]. 8ème congrès francophone de l'AfSep sur les sciences séparatives et les couplages, Marseille, France.

Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z

Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011

Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042

Piel, G., Boulmedarat, L., Bochot, A., Delattre, L., & Fattal, E. (May 2004). Influence of methyl-b-cyclodextrin on the relase kinetics of inulin encapsulated in bioadhesive liposomes [Poster presentation]. XII th International Cyclodextrin Symposium, Montpellier, France.

Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.